Bausch Health and YUN Team Up for Major Expansion in Mexico and EMEA Markets

Bausch Health and YUN Expand Their Horizons across EMEA and Mexico

In a significant move towards enhancing skincare solutions globally, Bausch Health Companies Inc. and the Belgian firm YUN have announced an expansion of their collaboration into Mexico and various EMEA (Europe, the Middle East, and Africa) markets. This strategic partnership aims to provide consumers with microbiome-friendly skincare products backed by science.

The collaboration, which showcases both companies’ commitment to innovation in healthcare, began in Poland back in 2025 and has since gathered momentum with recent launches throughout Europe. With Bausch Health's well-established distribution network and YUN's pioneering approach to probiotherapeutical skincare solutions, the two companies are set to make a noteworthy impact in the dermatology sector.

Scope of the Expansion

The expansion will see YUN's products, tailored specifically for acne and eczema-prone skin, becoming available in several key markets including the Czech Republic, Slovakia, Ukraine, and Bulgaria, alongside the new entry into the Mexican market. The launch of these offerings is anticipated to widen consumer access to dermatological care grounded in microbiome science, addressing the specific skincare needs that have evolved over time.

Fernando Zarate, Vice President of Latin America at Bausch Health, spoke on the significance of this launch: "We are augmenting our dermatology portfolio with innovations founded on microbiome science. Our aim is to meet the dynamic skincare needs in Mexico and improve access to superior dermatological solutions."

Cees Heiman, Bausch Health’s Senior Vice President for Europe and Canada, echoed this sentiment, stating the importance of accessing science-driven healthcare: "These launches reflect our commitment to bringing differentiated, science-based healthcare and skincare solutions to patients across the region. EMEA remains a strategically crucial area for us, and we recognize the high potential for YUN's microbiome-focused products in markets like Ukraine and Bulgaria."

YUN’s Innovative Approach

YUN has quickly established itself as a forward-thinking player in the biotech space, focusing on the integration of live probiotics within skincare formulations. Their proprietary YUN Probiotherapy™ platform offers solutions that harmonize with the skin’s natural microbiome, resulting in products that are effective and gentle. The technology entails combining live probiotics with various pre- and postbiotics and ensuring formulations respect the skin’s natural ecosystem.

Tom Verlinden, CEO of YUN, expressed pride in the extended collaboration, emphasizing their mission to leverage microbiome science for developing effective skincare solutions. He commented on the strategic choice of regions for expansion, sharing enthusiasm about the prospect of reaching more consumers by partnering with a company of Bausch Health's caliber.

Future Prospects

The collaboration is set to broaden further with a rollout planned in Kazakhstan for October 2026. This aligns with the vision of both companies to provide expanded access to microbiome principles in skincare products across numerous international markets.

A pivotal aspect of this partnership lies in their shared ambition to deliver quality so that customers across diverse demographics gain access to groundbreaking skincare innovations that can cater to skin conditions influenced by a myriad of external and internal factors.

As the skincare landscape continues to evolve, the extensive reach and integrated efforts of Bausch Health and YUN place them at the forefront of dermatological advancements. Through this partnership, they aim not only to develop leading-edge skincare solutions but also to influence a broader acceptance of microbiome science in everyday care practices worldwide.

With their sights set on future growth, both Bausch Health and YUN look forward to fostering consumer trust and enhancing health outcomes through their innovative skincare offerings.

For more information about YUN’s offerings, visit their website at YUN Probiotherapy.

About Bausch Health

Bausch Health Companies Inc. is a global, diversified pharmaceutical company dedicated to improving health outcomes for individuals worldwide. Their portfolio includes a range of healthcare products, and they maintain a commitment to delivering innovative solutions in multiple therapeutic areas.

About YUN

Founded in 2016, YUN is dedicated to revolutionizing care through microbiome science, creating effective and natural skincare products. Their dedication to excellence ensures that they remain a key player in the biotechnology landscape.